Researchers in Germany said a trial of COVID-19 vaccination administered through the nose has shown…
UPI By Clyde Hughes
April 3 (UPI) — Researchers in Germany said a trial of COVID-19 vaccination administered through the nose has shown great promise in animal testing, and they are preparing for first-stage clinical trials in humans.
The results of the nasal vaccine research were published Monday in the scientific journal Nature Microbiology.
Authors from the Freie UniversitĂ€t Berlin, Max DelbrĂŒck Center and CharitĂ© – UniversitĂ€tsmedizin Berlin said they developed a nasal vaccine that attacks COVID-19 where it often enters the body.
The body often expels droplets of saliva containing the virus while breathing and talking, coughing, sneezing or laughing. Other people then breathe in the airborne pathogens and become infected.
Read Full Article Here…(upi.com)
Home | Caravan to Midnight (zutalk.com)
